Recruiting A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses NCT06136403 Conditions Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +12 more Locations CHU de Nice — Nice, CHU de NICE, France APHP St Louis — Paris, France View Trial Details
Recruiting A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized NCT06509984 Conditions Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +8 more Locations CHU de Nice — Nice, France APHP Necker-Enfants-Malades — Paris, France APHP Hôpital Saint-Louis — Paris, France chu de Toulouse — Toulouse, France View Trial Details
Completed Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy NCT00001813 Conditions Abnormalities, Multiple, Bone Diseases, Bone Diseases, Developmental, +25 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
